【佳學(xué)基因檢測】了解精神疾病合并癥的分子遺傳學(xué)方法

基因變異引起的精神類疾病的合并癥的原理

學(xué)習(xí)神經(jīng)系統(tǒng)基因檢測全面性的標(biāo)準(zhǔn)與實(shí)施方案，記錄到《Dev Psychopathol》在.2016 Nov;28(4pt1):1089-1101發(fā)表了一篇題目為《了解精神疾病合并癥的分子遺傳學(xué)方法》精神病、神經(jīng)內(nèi)科疾病的多種臨床表現(xiàn)的應(yīng)對方案的臨床研究文章。該研究由Ian R Gizer等完成。促進(jìn)了復(fù)雜精神內(nèi)疾病的可行的診斷與治療方案，突出展示了基因信息分析，尤其是精神病的基因解碼基因檢測在合并癥類患者的正確診斷方面的作用。

神經(jīng)疾病遺傳阻斷及正確治療臨床研究內(nèi)容關(guān)鍵詞：

合并癥,并發(fā)癥,疾病診斷,分子遺傳學(xué),方法

精神科心理科疾病用藥指導(dǎo)基因檢測臨床應(yīng)用結(jié)果

流行病學(xué)研究表明，精神疾病在人群水平上的高并發(fā)率吸引了佳學(xué)基因等基因解碼機(jī)構(gòu)進(jìn)行了大量的研究。并發(fā)表了許多分析結(jié)果， 這些科研數(shù)據(jù)側(cè)重于確定這些疾病共發(fā)模式背后的因果機(jī)制。長期以來，此類努力一直是發(fā)育精神病理學(xué)家的核心焦點(diǎn)，賊近得到了 NIMH 制定的研究領(lǐng)域標(biāo)準(zhǔn)倡議的支持，該倡議為如何在不同分析水平上研究機(jī)制的假說提供了進(jìn)一步的框架。佳學(xué)基因神經(jīng)系疾病的基因解碼基因檢測重點(diǎn)介紹目前用于研究精神疾病病因的分子遺傳學(xué)方法，以及這些方法如何應(yīng)用于努力了解導(dǎo)致共病的生物學(xué)機(jī)制。采用精神科心理疾病致病基因鑒定基因解碼的技術(shù)，可以用于用于識別導(dǎo)致多種疾病風(fēng)險的個體變異的分子遺傳學(xué)方法以及導(dǎo)致其合并癥的干預(yù)生物學(xué)機(jī)制。隨后使用聚合遺傳數(shù)據(jù)來檢查這些問題的分子遺傳學(xué)方法，賊后討論了發(fā)育精神病理學(xué)家如何以獨(dú)特的方式應(yīng)用這些方法，從而進(jìn)一步了解導(dǎo)致這些問題的因果因素。有助于合并癥的診斷技術(shù)和個性化治療藥物的發(fā)展。

神經(jīng)及精神疾病及其并發(fā)征、合并征國際數(shù)據(jù)庫描述：

Epidemiologic studies demonstrating high rates of co-occurrence among psychiatric disorders at the population level have contributed to large literatures focused on identifying the causal mechanisms underlying the patterns of co-occurrence among these disorders. Such efforts have long represented a core focus of developmental psychopathologists and have more recently been supported by the Research Domain Criteria initiative developed by the NIMH, which provides a further framework for how the hypothesized mechanisms can be studied at different levels of analysis. The present overview focuses on molecular genetic approaches that are being used currently to study the etiology of psychiatric disorders, and how these approaches have been applied in efforts to understand the biological mechanisms that give rise to comorbid conditions. The present report begins with a review of molecular genetic approaches used to identify individual variants that confer risk for multiple disorders and the intervening biological mechanisms that contribute to their comorbidity. This is followed by a review of molecular genetic approaches that use genetic data in aggregate to examine these questions, and concludes with a discussion of how developmental psychopathologists are uniquely positioned to apply these methods in a way that will further our understanding of the causal factors that contribute to the development of comorbid conditions.